Genworth Financial Inc

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed April 26, 2024), Genworth Financial Inc reported 2 stock positions worth $346.4 million. Its top holding was iShares Core S&P 500 ETF (IVV) at 91.3% of the portfolio, followed by Invesco S&P 500 Low Volatili (SPLV, 8.7%). Compared with Q4 2023, it sold out of 2 and added to 1. The biggest buy was Invesco S&P 500 Low Volatili (SPLV, shares +1%) and the biggest sale an exit from Mirum Pharmaceuticals (MIRM).

Most Recent 13F
Q2 2026
Location
Glen Allen, VA
CIK
0001276520
Portfolio Value
$346.4M (Q1 2024)
SEC Filing
0000950123-24-003542 ↗ filed Apr 26, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $346.4M $346.4M Q1 2024 Q2 2024: $359.1M Q2 2024 Q3 2024: $380.2M Q3 2024 Q4 2024: $386.6M Q4 2024 Q1 2025: $372.9M Q1 2025 Q2 2025: $407.7M Q2 2025 Q3 2025: $437.2M Q3 2025 Q4 2025: $445.8M Q4 2025 Q1 2026: $427.7M Q1 2026 Q2 2026: $486.1M Q2 2026

Holdings 2 stocks · $346.4M

IVV iShares Core S&P 500 ETF 91.29% 601,470 $316.2M No change
SPLV Invesco S&P 500 Low Volatili 8.71% 458,287 $30.2M Add +0.7%

Portfolio Sells Q4 2023 → Q1 2024

MIRM Mirum Pharmaceuticals Inc. Sold out 0.00% −0.12
UDMY Udemy Inc. Sold out 0.00% −0.00

Portfolio Buys Q4 2023 → Q1 2024

SPLV Invesco S&P 500 Low Volatili Add +0.7% 8.71% −0.31

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$486.1MIVV, SPLV
Q1 2026 2$427.7MIVV, SPLV
Q4 2025 2$445.8MIVV, SPLV
Q3 2025 2$437.2MIVV, SPLV
Q2 2025 2$407.7MIVV, SPLV
Q1 2025 2$372.9MIVV, SPLV
Q4 2024 2$386.6MIVV, SPLV
Q3 2024 2$380.2MIVV, SPLV
Q2 2024 2$359.1MIVV, SPLV
Q1 2024 2$346.4MIVV, SPLV